Maxwell A. Gyamfi
Maxwell A. Gyamfi publishes mostly in Molecular Biology, Pharmacology and Epidemiology, on topics such as Liver Disease Diagnosis and Treatment, Peroxisome Proliferator-Activated Receptors and Pharmacogenetics and Drug Metabolism.
- World rank
- #1,303,438 of 7,710,434 ranked researchers
- Rank in United States
- #414,458 of 1,627,098
- Works
- 48
- Citations
- 2.4k
- Citations per work
- 50.6
What does Maxwell A. Gyamfi research?
Maxwell A. Gyamfi's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (27%), Pharmacology, Toxicology and Pharmaceutics (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2245.7%
- Health Sciences1327.2%
- Medicine1327.2%
- Everything else1327.1%
- 1Molecular Biology24% of their works
- 2Pharmacology14% of their works
- 3Epidemiology13% of their works
- 4Cancer Research7% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Pathology and Forensic Medicine7% of their works
Research topics
- Liver Disease Diagnosis and Treatment
- Peroxisome Proliferator-Activated Receptors
- Pharmacogenetics and Drug Metabolism
- Alcohol Consumption and Health Effects
- Drug-Induced Hepatotoxicity and Protection
- Genomics, phytochemicals, and oxidative stress
- Hormonal Regulation and Hypertension
- Cancer, Lipids, and Metabolism
Which keywords describe Maxwell A. Gyamfi's research?
The keywords of their largest research topics: Inflammation, Oxidative Stress, Metabolism, Metabolic Syndrome, NAFLD, NASH, Peroxisome Proliferator-Activated Receptors and PPARs.
- Fatty Acid Synthase
- Nrf2
- Aldosterone
- Drug-Induced Liver Injury
- Cancer
- Pharmacogenetics
- Peroxisome Proliferator-Activated Receptors
- NASH
- Metabolic Syndrome
- Oxidative Stress
- Inflammation
- Metabolism
- NAFLD
- PPARs
- Cytochrome P450
- Alcohol
- Liver Disease
- Hepatotoxicity
- Keap1-Nrf2-ARE Pathway
- Primary Aldosteronism
- Lipid Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Inflammation253 topics
- Oxidative Stress223 topics
- Metabolism202 topics
- Metabolic Syndrome182 topics
- NAFLD131 topic
- NASH131 topic
- PPARs111 topic
- Peroxisome Proliferator-Activated Receptors111 topic
- Cytochrome P450101 topic
- Pharmacogenetics101 topic
- Alcohol91 topic
- Cancer92 topics
- Liver Disease91 topic
- Drug-Induced Liver Injury81 topic
- Hepatotoxicity81 topic
- Aldosterone51 topic
- Keap1-Nrf2-ARE Pathway51 topic
- Nrf251 topic
- Primary Aldosteronism51 topic
- Fatty Acid Synthase41 topic
- Lipid Metabolism41 topic
Where does Maxwell A. Gyamfi work?
Maxwell A. Gyamfi's main affiliation in the publication record is North Carolina Central University, United States.
How many publications and citations does Maxwell A. Gyamfi have?
OpenAlex counts 48 works and 2,430 citations for Maxwell A. Gyamfi, an h-index of 25, ranking #1,303,438 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Maxwell A. Gyamfi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.